Explore AM-11542 | TiHKAL

ChemSpider 26383682
PubChem 53318931

Shulgin, AT. Chemistry of psychotomimetics. In Handbook of Experimental Pharmacology. Psychotropic Agents, Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs; Hoffmeister, F; Stille, G, Eds., Springer-Verlag, Berlin, 1 Jan 1982; Vol. 55 (3), pp 3–29. 928 kB. https://doi.org/10.1007/978-3-642-67770-0_1 #13f

Shulgin, AT. Psychotomimetic agents. In Psychopharmacological Agents; Gordon, M, Ed., Academic Press, New York, 1 Jan 1976; Vol. 4, pp 59–146. 3.1 MB.

Shulgin, AT. Hallucinogens. In Burger’s Medicinal Chemistry, 4th ed., Part III; Wolff, ME, Ed., John Wiley & Sons, Inc., 1 Jan 1981; pp 1109–1137. 4.7 MB. #43f

Hua, T; Vemuri, K; Nikas, SP; Laprairie, RB; Wu, Y; Qu, L; Liu, Z. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature, 1 Jul 2017, 547 (7664), 468–471. 13.4 MB. https://doi.org/10.1038/nature23272 #AM11542

Floresta, G; Apirakkan, O; Rescifina, A; Abbate, V. Discovery of high-affinity cannabinoid receptors ligands through a 3D-QSAR ushered by scaffold-hopping analysis. Molecules, 30 Aug 2018, 23 (9), 2183. 4.1 MB. https://doi.org/10.3390/molecules23092183 #AM11542